CymaBay Therapeutics, Inc.

STATE STREET CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

2,797,916

Value ($000)

66,087

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	66,087	0.0%	2,797,916	12/31/2023
2023 Q3	11/14/2023	34,083	0.0%	2,285,944	9/30/2023
2023 Q2	8/14/2023	25,278	0.0%	2,308,493	6/30/2023
2023 Q1	5/15/2023	5,834	0.0%	669,036	3/31/2023
2022 Q4	5/15/2023	2,121	0.0%	338,273	12/31/2022
2022 Q3	11/15/2022	1,184	0.0%	338,273	9/30/2022
2022 Q2	8/15/2022	1,068	0.0%	362,120	6/30/2022
2022 Q1	5/16/2022	4,224	0.0%	1,358,050	3/31/2022
2021 Q4	2/14/2022	4,509	0.0%	1,333,890	12/31/2021
2021 Q3	11/15/2021	4,661	0.0%	1,276,967	9/30/2021
2021 Q2	8/16/2021	5,917	0.0%	1,357,224	6/30/2021
2021 Q1	7/9/2021	5,860	0.0%	1,290,846	3/31/2021
2020 Q4	2/16/2021	10,380	0.0%	1,808,347	12/31/2020
2020 Q3	11/10/2020	11,877	0.0%	1,640,514	9/30/2020
2020 Q2	8/14/2020	4,937	0.0%	1,414,471	6/30/2020
2020 Q1	6/19/2020	2,104	0.0%	1,421,566	3/31/2020
2019 Q4	2/6/2020	2,763	0.0%	1,409,914	12/31/2019